Device Trial Radar · NCT06722755
Stroke and CPAP Outcome Study 3 Randomized Controlled Trial
Last checked: Nov 20, 2026Latest source record: Aug 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
250
Planned (sponsor's estimate)
Start
Jan 15, 2025
Primary completion
Apr 2028
Study completion May 2028
Sponsor
- Lead sponsor
- University of WashingtonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- First posted
- Dec 9, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The SCOUTS 3 study aims to test the effectiveness of an intensive CPAP (Continuous Positive Airway Pressure) therapy support program compared to usual care in stroke patients with obstructive sleep apnea (OSA) during inpatient rehabilitation (IPR). The study is a multicenter randomized controlled trial (RCT) involving recruitment of about 250 participants across two institutions and randomization of about 200 participants. It compares an intensive support (IS) program for CPAP use with standard support (SS) to evaluate the effectiveness of the IS intervention in increasing CPAP usage during and after stroke rehabilitation. The Intensive Support (IS) group will receive a multicomponent intensive behavioral adherence program, which includes a CPAP technical support intervention, Motivational Enhancement Therapy (MET), and a Mobile Health intervention. Outcomes measured include CPAP adherence as measured by average nightly use in minutes between randomization and 3 months and the modified Rankin Scale (mRS-9Q) to evaluate stroke recovery.
Conditions
- Stroke Patients
- CPAP
- OSA - Obstructive Sleep Apnea
Interventions
CPAP deviceDevice
Eligible participants with OSA will be started on automatically-adjusting CPAP.
CPAP technical supportBehavioral
Trained personnel will conduct mask selection and fitting, provide continual troubleshooting, and train participants on CPAP.
Phone follow-up for adherence feedback and self-management skillsBehavioral
The research coordinator will call participants approximately monthly to provide any needed support.
myAirBehavioral
Study personnel will assist participants in registering for and using the myAir (ResMed) self-tracking app. This app also provides a library of how-to videos and provides email updates to participants.
Tailored messagesBehavioral
Tailored text messages will be sent to participants. Two-way texting messaging will also be available between the study team and participants.
Written MaterialsBehavioral
A binder of written educational materials will be provided to participants.
Motivational Enhancement Therapy (MET)Behavioral
A trained sleep coach will conduct up to 5 MET sessions with participants and 2 sessions with a CPAP partner during the study time period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- CPAP AdherenceTime frame: 3 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Rancho Research Institute
Downey, California · Recruiting
University of Washington - Harborview Medical Center
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.